Trials / Completed
CompletedNCT05312528
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Diagnostic Value of Annexin V, sVCAM-1, sICAM-1, Vascular Endothelial Growth Factor, TNF Alpha and Interleukin-6 in Ovarian and Deep Infiltrating Endometriosis, the Changes of These Markers in the Postoperative Period
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Bagcilar Training and Research Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The diagnostic value of Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and Proinflammatory cytokines (TNF-a and interleukin-6) in ovarian endometriosis and deep infiltrating endometriosis, their levels in organ-specific involvement, their relationship with symptoms, and the changes of these markers in the postoperative period will be evaluated.
Detailed description
Serum Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and proinflammatory cytokines (TNF-a and interleukin-6) values were studied by taking blood samples from all patients before and three months after the operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | endometriosis surgery | Laparoscopy was performed in the follicular phase of the woman's menstrual cycle and all recognizable endometriotic lesions were treated by bipolar coagulation, resection of endometriotic nodules and ovarian cystectomy. |
| PROCEDURE | other benign condition surgeries | ovarian cystectomy, bilateral tubal ligation, myomectomy etc. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-02-01
- Completion
- 2019-03-01
- First posted
- 2022-04-05
- Last updated
- 2022-04-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05312528. Inclusion in this directory is not an endorsement.